Literature DB >> 10565939

Production of monoclonal antibodies directed against the microsporidium Enterocytozoon bieneusi.

I Accoceberry1, M Thellier, I Desportes-Livage, A Achbarou, S Biligui, M Danis, A Datry.   

Abstract

Several hybridomas producing antibodies detected by indirect immunofluorescence antibody test (IFAT) were established by fusion of mouse myeloma SP2/O with spleen cells from BALB/c mice immunized against whole spores (protocol 1) or chitinase-treated spores (protocol 2) of Enterocytozoon bieneusi and were cloned twice by limiting dilutions. Two monoclonal antibodies (MAbs), 3B82H2 from protocol 1, isotyped as immunoglobulin M (IgM), and 6E52D9 from protocol 2, isotyped as IgG, were expanded in both ascites and culture. IFAT with the MAbs showed that both MAbs reacted exclusively with the walls of the spores of E. bieneusi, strongly staining the surface of mature spores, and produced titers of greater than 4,096. Immunogold electron microscopy confirmed the specific reactivities of both antibodies. No cross-reaction, either with the spores of the other intestinal microsporidium species Encephalitozoon intestinalis or with yeast cells, bacteria, or any other intestinal parasites, was observed. The MAbs were used to identify E. bieneusi spores in fecal specimens from patients suspected of having intestinal microsporidiosis. The IFAT was validated against standard staining methods (Chromotrope 2R and Uvitex 2B) and PCR. We report here the first description and characterization of two MAbs specific for the spore wall of E. bieneusi. These MAbs have great potential for the demonstration and species determination of E. bieneusi, and their application in immunofluorescence identification of E. bieneusi in stool samples could offer a new diagnostic tool for clinical laboratories.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10565939      PMCID: PMC85891     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

1.  Specific PCR assay for direct detection of intestinal microsporidia Enterocytozoon bieneusi and Encephalitozoon intestinalis in fecal specimens from human immunodeficiency virus-infected patients.

Authors:  C Ombrouck; L Ciceron; S Biligui; S Brown; P Marechal; T van Gool; A Datry; M Danis; I Desportes-Livage
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

Review 2.  Enterocytozoon bieneusi infection and diarrheal disease in patients who were not infected with human immunodeficiency virus: case report and review.

Authors:  C A Wanke; P DeGirolami; M Federman
Journal:  Clin Infect Dis       Date:  1996-10       Impact factor: 9.079

3.  Use of discontinuous Percoll gradients to isolate Cyclospora oocysts.

Authors:  C E Medina-De la Garza; H L García-López; M C Salinas-Carmona; D J González-Spencer
Journal:  Ann Trop Med Parasitol       Date:  1997-04

4.  Asymptomatic intestinal microsporidiosis in a human immunodeficiency virus-seronegative, immunocompetent Zambian child.

Authors:  J L Hautvast; J J Tolboom; T J Derks; P Beckers; R W Sauerwein
Journal:  Pediatr Infect Dis J       Date:  1997-04       Impact factor: 2.129

5.  Intestinal microsporidiosis occurring in a liver transplant recipient.

Authors:  P E Sax; J D Rich; W S Pieciak; Y M Trnka
Journal:  Transplantation       Date:  1995-09-27       Impact factor: 4.939

6.  Self-limited traveller's diarrhea due to a dual infection with Enterocytozoon bieneusi and Cryptosporidium parvum in an immunocompetent HIV-negative child.

Authors:  I Sobottka; H Albrecht; J Schottelius; C Schmetz; M Bentfeld; R Laufs; D A Schwartz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-10       Impact factor: 3.267

7.  High seroprevalence of Encephalitozoon species in immunocompetent subjects.

Authors:  T van Gool; J C Vetter; B Weinmayr; A Van Dam; F Derouin; J Dankert
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

8.  Enterocytozoon bieneusi as a cause of chronic diarrhea in a heart-lung transplant recipient who was seronegative for human immunodeficiency virus.

Authors:  M Rabodonirina; M Bertocchi; I Desportes-Livage; L Cotte; H Levrey; M A Piens; G Monneret; M Celard; J F Mornex; M Mojon
Journal:  Clin Infect Dis       Date:  1996-07       Impact factor: 9.079

9.  Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study. The French Microsporidiosis Study Group.

Authors:  J M Molina; J Goguel; C Sarfati; C Chastang; I Desportes-Livage; J F Michiels; C Maslo; C Katlama; L Cotte; C Leport; F Raffi; F Derouin; J Modaï
Journal:  AIDS       Date:  1997-11       Impact factor: 4.177

10.  Encephalocytozoon intestinalis-specific monoclonal antibodies for laboratory diagnosis of microsporidiosis.

Authors:  P J Beckers; G J Derks; T Gool; F J Rietveld; R W Sauerwein
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

View more
  18 in total

Review 1.  Laboratory identification of the microsporidia.

Authors:  Lynne S Garcia
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  One-step purification of Enterocytozoon bieneusi spores from human stools by immunoaffinity expanded-bed adsorption.

Authors:  I Accoceberry; M Thellier; A Datry; I Desportes-Livage; S Biligui; M Danis; X Santarelli
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Production and characterization of monoclonal antibodies against Enterocytozoon bieneusi purified from rhesus macaques.

Authors:  Quanshun Zhang; Inderpal Singh; Abhineet Sheoran; Xiaochuan Feng; John Nunnari; Angela Carville; Saul Tzipori
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Monoclonal antibodies against Enterocytozoon bieneusi of human origin.

Authors:  Abhineet S Sheoran; Xiaochuan Feng; Inderpal Singh; Susan Chapman-Bonofiglio; Sabrina Kitaka; Joel Hanawalt; John Nunnari; Keith Mansfield; James K Tumwine; Saul Tzipori
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

5.  Evaluation of an immunofluorescent-antibody test using monoclonal antibodies directed against Enterocytozoon bieneusi and Encephalitozoon intestinalis for diagnosis of intestinal microsporidiosis in Bamako (Mali).

Authors:  O Alfa Cisse; A Ouattara; M Thellier; I Accoceberry; S Biligui; D Minta; O Doumbo; I Desportes-Livage; M A Thera; M Danis; A Datry
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

6.  Purification of Enterocytozoon bieneusi from stools and production of specific antibodies.

Authors:  Abhineet S Sheoran; Xiaochuan Feng; Sabrina Kitaka; Linda Green; Christine Pearson; Elizabeth S Didier; Susan Chapman; James K Tumwine; Saul Tzipori
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

7.  Discrimination between viable and dead Encephalitozoon cuniculi (Microsporidian) spores by dual staining with sytox green and calcofluor white M2R.

Authors:  L C Green; P J LeBlanc; E S Didier
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

8.  Purification of Enterocytozoon bieneusi spores from stool specimens by gradient and cell sorting techniques.

Authors:  Zuzana Kucerova; Hercules Moura; Gordon J Leitch; Rama Sriram; Caryn Bern; Vivian Kawai; Daniel Vargas; Robert H Gilman; Eduardo Ticona; Aldo Vivar; Govinda S Visvesvara
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

9.  Evaluation of Immunoflourescence antibody assay for the detection of Enterocytozoon bieneusi and Encephalitozoon intestinalis.

Authors:  Ujjala Ghoshal; Sonali Khanduja; Priyannk Pant; Uday C Ghoshal
Journal:  Parasitol Res       Date:  2016-05-20       Impact factor: 2.289

10.  New highly divergent rRNA sequence among biodiverse genotypes of Enterocytozoon bieneusi strains isolated from humans in Gabon and Cameroon.

Authors:  Jacques Breton; Emmanuelle Bart-Delabesse; Sylvestre Biligui; Alessandra Carbone; Xavier Seiller; Madeleine Okome-Nkoumou; Chantal Nzamba; Maryvonne Kombila; Isabelle Accoceberry; Marc Thellier
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.